Please sign in to follow a disease.

Chemotherapy-induced myelosuppression

Clinical trials for Chemotherapy-induced myelosuppression explained in plain language.

Never miss a new study

Get alerted when new Chemotherapy-induced myelosuppression trials appear

Sign up with your email to follow new studies for Chemotherapy-induced myelosuppression, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New drug cuts chemotherapy side effect by over 60% in breast cancer patients

Disease control Completed

This study tested whether Naderin, an immune-boosting drug, could prevent low white blood cell counts in 79 women with breast cancer receiving first-line chemotherapy. Participants either received Naderin alongside chemotherapy or chemotherapy alone. The results showed that only …

Matched conditions: CHEMOTHERAPY-INDUCED MYELOSUPPRESSION

Phase 2/3 • Sponsor: MIPO Clinic • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

Chemotherapy-induced myelosuppression

Get alerted when new Chemotherapy-induced myelosuppression trials appear

New drug cuts chemotherapy side effect by over 60% in breast cancer patients